Bank of New York Mellon Corp - PLX PHARMA INC ownership

PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 49 filers reported holding PLX PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of PLX PHARMA INC
ValueSharesWeighting
Q1 2022$43,000
-49.4%
10,6150.0%0.00%
Q4 2021$85,000
-93.6%
10,615
-84.5%
0.00%
Q3 2021$1,325,000
+826.6%
68,664
+564.2%
0.00%
Q2 2021$143,000
+53.8%
10,3380.0%0.00%
Q1 2021$93,00010,3380.00%
Other shareholders
PLX PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 62,673$346,0000.38%
Park West Asset Management LLC 1,473,218$8,132,0000.17%
Heritage Way Advisors, LLC 41,712$230,0000.11%
Cranbrook Wealth Management, LLC 7,500$41,0000.01%
683 Capital Management, LLC 30,000$166,0000.01%
Renaissance Technologies 139,083$768,0000.00%
WELLS FARGO & COMPANY/MN 460$2,0000.00%
NORTHERN TRUST CORP 10,043$55,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 15,326$85,0000.00%
View complete list of PLX PHARMA INC shareholders